KPIs & Operating Metrics(New)
Balance Sheet
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Takeda Pharmaceutical (TAK) Inventory Average (2019 - 2025)

Takeda Pharmaceutical (TAK) has 7 years of Inventory Average data on record, last reported at $8.1 billion in Q1 2025.

  • For Q1 2025, Inventory Average rose 3.34% year-over-year to $8.1 billion; the TTM value through Mar 2025 reached $8.1 billion, up 3.34%, while the annual FY2025 figure was $8.2 billion, 4.4% up from the prior year.
  • Inventory Average reached $8.1 billion in Q1 2025 per TAK's latest filing, up from $7.8 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $8.1 billion in Q1 2025 and bottomed at $7.0 billion in Q1 2021.
  • Average Inventory Average over 5 years is $7.5 billion, with a median of $7.4 billion recorded in 2023.
  • Peak YoY movement for Inventory Average: decreased 8.03% in 2021, then grew 5.56% in 2024.
  • A 5-year view of Inventory Average shows it stood at $7.0 billion in 2021, then grew by 2.59% to $7.2 billion in 2022, then grew by 2.32% to $7.4 billion in 2023, then increased by 5.56% to $7.8 billion in 2024, then grew by 3.34% to $8.1 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $8.1 billion in Q1 2025, $7.8 billion in Q1 2024, and $7.4 billion in Q1 2023.